Navigation Links
Blue Cross of California Reaches Out to Members Impacted by Southern California Fires
Date:10/26/2007

WOODLAND HILLS, Calif., Oct. 26 /PRNewswire/ -- In addition to a $50,000 donation made earlier this week from the Blue Cross of California Foundation to the American Red Cross to aid in the disaster relief in Southern California, Blue Cross announced today several additional actions they are taking to assist members affected by the fires:

Blue Cross of California Employee Assistance Program (EAP): The Blue Cross EAP is offering free counseling services for the next 30 days to all Blue Cross members throughout the impacted area. Services include access to a resource rich website and telephonic consultations with professional counselors. In addition, they offer face-to-face consultations. The EAP program is available 24 hours a day by calling toll free 877-208-8240, or members can visit the website at http://www.bluecrossca.com/youreap and enter "fires".

Prescriptions: Blue Cross members may have left their homes without their prescriptions or they may have been damaged during this disaster. While many prescriptions are refillable on a 30 day cycle, Blue Cross is providing a one- time 30-day supply override on affected members' prescriptions. This will enable members to refill their prescriptions now, even if it is not due at this time.

For members in the impacted communities who participate in the Blue Cross mail order prescription program, Blue Cross is checking in advance of shipping, that the member will be able to receive their mail order. They will re-route orders as needed at no charge to the members. Members who cannot get to their homes to receive their mail prescriptions but feel the medication was sent prior to the fires occurring are encouraged to contact their local post office for details of where mail for their area is being deposited at this time.

Member Medical Claims: During this time, many clinics and other medical facilities have been closed. In addition m
'/>"/>

SOURCE Blue Cross of California
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Memory problem? solve a crossword
2. FDA attacks American Red Cross for blood violations
3. Encephalitis Death Toll In U.P. Crosses 200 Mark.
4. Encephalitis Deaths Cross 220 in Uttar Pradesh
5. Flu-Drugs Are Causing Resistance Across The World
6. Condom Vending Machines To Be Installed Across Indian States
7. First Crossover Kidney Transplantation In Germany
8. Bird Flu Infection Of Chinese Girl Prompts Fear Of Spread Across Asia
9. Chicken pox Spreads Across Firozabad
10. The Cleveland Clinic Expands Its Services across the World via the Net
11. Blue Cross Signs Up 110,000 Minnesotans For Part D Medicare Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...Michigan received $5 million from the National Ins...esource of high-quality experimental data sets of ...mputer-aided drug design to a new level. , The ...puter programs that can predict the effectiveness ...ciate professor in the U-M College of Pharmacy and...
(Date:10/10/2008)... Johns Hopkins University School,of Medicine is la...ptimizing Adjuvant Breast Cancer Strategies: From ...ent key research data on the latest advances in,br...ents in the treatment of breast cancer have,led to...ons that are,increasingly tailored to the specific...
(Date:10/10/2008)... The Mobile Massage Team, (http://www.mobilemassag...massage,services for corporate wellness programs, ... today that it is expanding its service area throu...lphia metropolitan region., "We are quite excited...ed, massage programs and services throughout both...
(Date:10/10/2008)...nationally recognized faculty will,present the ver...east,cancer in the multimedia course "Optimizing A...to Treatment Selection" during National Breast,Can...icing oncologists and other interested,health care...t care,advances. This accredited course offers con...
Breaking Medicine News(10 mins):Health News:U-M to house leading drug database 2Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2
...ey gene that controls specialized brain cells// is...isorders and lead to better treatment of condition..., researchers said Wednesday. The National Univer...iled a new gene that speeds up the growth of the b...
... for longer times than others may be// having deve...ntists. Linda Crowe, associate professor in the co...as State University, said that it’s important for ...ren are having any language delays. Language delay...
...e the age of 80yrs, may remain at a higher risk fr...ndetected for long as well. The report, which was ...bout 75% of the participants of the survey conduct...ertension. The research, which was based on data f...
... Association (IMA) has today warned its members// ...reating or dealing with patients who suffer from b... of the Maoist violence taking place in the neighb...nha of Muzaffarpur district was arrested in May fo...
Other Medicine News:Health News:Language Delays May Not Be Normal In Children 2Health News:Elderly Women Remain At Risk From Hypertension 2
(Date:10/8/2008)...s Research That May Offer New Hope to,Heart Failur...nally, over 3,000 people are,waiting for a heart t...alf,of those will receive a transplant. Now, pione... paving the way for how to treat congestive heart,...ews Release, go to:, http://www.prnewswire.com/mnr...
(Date:10/8/2008)...e TAXUS(R) Element(TM) Platinum Chromium ... 8 /- Boston Scientific,Cor... completed enrollment in,the PERSEUS trial, design...S(R) Element(TM) paclitaxel-eluting coronary stent... 1,500 patients at 100 U.S. and,international cent...
(Date:10/8/2008)...ical improvement in patients with pulmonary a...t options have limited benefit for this debilitati...essel disease, -- Imatinib mesylate, available ...s, known to inhibit protein associated with PAH, ...inib mesylate in PAH in 2009 EAST HANOVER, N...
(Date:10/7/2008)... device for detecting polyps that can be ...Fla., Oct. 7 /- At the American Colle...n Orlando (ACG 2008), renowned,gastroenterologist ...institutional clinical study that evaluated the ef...vice that is designed to improve the ability,of ph...
Breaking Medicine Technology:Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Handbook helps parents deal with childhood infections 1024 1Handbook helps parents deal with childhood infections 1024 2Speed plays crucial role in breaking proteins H bonds 1022 1Speed plays crucial role in breaking proteins H bonds 1022 2Speed plays crucial role in breaking proteins H bonds 1022 3Fuel cells gearing up to power auto industry 1020 1Fuel cells gearing up to power auto industry 1020 2Fuel cells gearing up to power auto industry 1020 3Michigan Cosmetic Surgeon Debunks Top 3 Breast Implant Myths 4974 1Michigan Cosmetic Surgeon Debunks Top 3 Breast Implant Myths 4974 2
...eady being treated with maximally,tolerated lipid-...ons in LDL-C with similar reductions in other athe... NEW ORLEANS, and CARLSBAD, Calif., March 26, 2007...nc. announced,results from its ongoing Phase 2 cli...gous familial hypercholesterolemia (HoFH),present...
... 2007 /PRNewswire-FirstCall/ --,Alfacell Corporati...nstrating the potential of ONCONASE (ranpirnase) f...CLC) were recently,published in Anticancer Researc...ae Lee, Ph.D., at the University of,Pennsylvania, ...xic,RNase, Ranpirnase, on A549 Human Lung Cancer X...
Other Medicine Technology:Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 2Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 3Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 4Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 5Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 6In vivo Study Results Demonstrating Potential of Alfacell's,Onconase for Treatment of Non-Small Cell Lung Cancer Published in,Anticancer Research 2In vivo Study Results Demonstrating Potential of Alfacell's,Onconase for Treatment of Non-Small Cell Lung Cancer Published in,Anticancer Research 3
Last 3-6 months average refrigeration will prolong life. Pupil gauge printed on penlight 4 1/2" long 1/2" around.
Maxi-Lite diagnostic penlight features a twist-on backswitch.
Heavy duty, all purpose illuminator available in blue and green. Unique Clip Switch automatically turns off when returned to pocket. Pre-focused lens tip Heine XHL Halogen bulb for bright, concentra
Heavy duty, all purpose illuminator available in black only. Unique Clip Switch automatically turns off when returned to pocket. Pre-focused lens tip Heine XHL Halogen bulb for bright, concentrated l
Medicine Products: